Why We're Passionate
Commitment to Humanity
Atherosclerosis is the leading cause of mortality in the USA and globally. Statins are a current standard of care, but these only attempt to prevent plaque formation, and the numbers don't lie. One in every five deaths are still cardiac-related and this fact is unacceptable. Unlike interventions that seek to prevent future plaques, we're targeting the root cause and aiming to clear existing plaques that have already formed.
Groundbreaking Innovation
We leverage a vaccine platform, called a virus-like particle, to target a cell type that drives the aging process. Scientific evidence has linked this cell type to plaque formation, and clearance has shown incredible benefits. Based on preclinical readouts, our vaccine shows double the efficacy of today's best statins. What's more, our studies will soon verify whether this vaccine can clear existing plaques, illustrating a true cure. Once these data are solidified, the pathway to clinical trials is clear.
The Power of Targeting Aging
Outside of atherosclerosis, we have observed therapeutic benefits across every organ system monitored. These include pulmonary protections, hair loss reductions, prolapse prevention, and even lifespan extension. Imagine the diseases that can be mitigated from targeting the aging process itself. This is the power from targeting a driver of human aging.
A Vaccine for All Who Desire It
Financial projections place this vaccine as cost-competitive with statins while providing multi-morbidity intervention capabilities. After scale, we project further cost reductions to the consumer. Our platform can also be manufactured in a thermostable fashion, allowing for global expansion into the furthest reaches of the Earth. We're on a mission to allow everyone a choice in vaccination, regardless of socioeconomic status or geopolitical position.
Contact Us
